Tech Company Financing Transactions
Tenvie Therapeutics Funding Round
On 1/8/2025, Tenvie Therapeutics raised $200 million in funding from Arch Venture Partners, F-Prime Capital and Mubadala.
Transaction Overview
Company Name
Announced On
1/8/2025
Transaction Type
Venture Equity
Amount
$200,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its growth and development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA Undisclosed
USA
San Francisco, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Tenvie Therapeutics, a San Francisco, CA-based biotechnology company committed to engineering small molecules for the treatment of neurological diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tony Estrada
Browse more venture capital transactions:
Prev: 1/8/2025: Siren venture capital transaction
Next: 1/8/2025: Karman Industries venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs